35
Participants
Start Date
May 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
pazopanib hydrochloride
Given orally
laboratory biomarker analysis
Correlative studies
Memorial Sloan-Kettering Cancer Center, New York
University of Pittsburgh, Pittsburgh
National Cancer Institute Neuro-Oncology Branch, Bethesda
Duke University, Durham
University of Wisconsin, Madison
MD Anderson Cancer Center, Houston
University of California Los Angeles, Los Angeles
University of California San Francisco, San Francisco
Dana Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH